Mark J. Benotti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mark J. Benotti has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Shane Allen Snyder
Georgia Institute of Technology
3 shared publications Benjamin D. Stanford
1 shared publicationEric C. Wert
1 shared publication
Latest Publications
- 1 January 2010
- Published by IWA Publishing in Water Science & Technology
- Vol. 61 (1) , 145-154
Endocrine disruptors and pharmaceuticals: implications for water sustainability
The presence of pharmaceuticals and endocrine disrupting compounds (EDCs) in the environment raises many questions about risk to the environment and risk to human health. Researchers have attributed adverse ecological effect effects to the presence of these compounds, particularly EDCs, though there is no consensus on what risk, if any, these compounds pose to human health. The scientific community is in the process of developing a better understanding of the occurrence, fate, and transport of pharmaceuticals and EDCs in the environment, including a better characterization of human exposure via drinking water. This paper provides a brief review of pharmaceuticals and EDCs in drinking water, as well as uses examples from Lake Mead, Nevada, USA, to highlight the issues associated with their fate and transport. Lastly, the effects of natural or anthropogenically driven processes, like natural seasonal flow or climate-change/prolonged drought are discussed as they are factors which can drastically alter environmental concentrations of these compounds. Without question, the propensity for the contamination of fresh water will rise as (1) human population continues to grow or (2) patterns of natural surface water slow and wastewater becomes a larger fraction of flow further highlighting the need for a more comprehensive understanding of their environmental behavior.
- 1 January 2010
- Published by IWA Publishing in Water Science & Technology
- Vol. 61 (1) , 145-154
Endocrine disruptors and pharmaceuticals: implications for water sustainability
The presence of pharmaceuticals and endocrine disrupting compounds (EDCs) in the environment raises many questions about risk to the environment and risk to human health. Researchers have attributed adverse ecological effect effects to the presence of these compounds, particularly EDCs, though there is no consensus on what risk, if any, these compounds pose to human health. The scientific community is in the process of developing a better understanding of the occurrence, fate, and transport of pharmaceuticals and EDCs in the environment, including a better characterization of human exposure via drinking water. This paper provides a brief review of pharmaceuticals and EDCs in drinking water, as well as uses examples from Lake Mead, Nevada, USA, to highlight the issues associated with their fate and transport. Lastly, the effects of natural or anthropogenically driven processes, like natural seasonal flow or climate-change/prolonged drought are discussed as they are factors which can drastically alter environmental concentrations of these compounds. Without question, the propensity for the contamination of fresh water will rise as (1) human population continues to grow or (2) patterns of natural surface water slow and wastewater becomes a larger fraction of flow further highlighting the need for a more comprehensive understanding of their environmental behavior.
- 1 July 2009
- Published by Wiley in Groundwater
- Vol. 47 (4) , 499-502
Pharmaceuticals and Endocrine Disrupting Compounds: Implications for Ground Water Replenishment with Recycled Water
- 1 July 2009
- Published by Wiley in Groundwater
- Vol. 47 (4) , 499-502
Pharmaceuticals and Endocrine Disrupting Compounds: Implications for Ground Water Replenishment with Recycled Water
- 1 April 2009
- Published by Elsevier in Water Research
- Vol. 43 (6) , 1513-1522
Evaluation of a photocatalytic reactor membrane pilot system for the removal of pharmaceuticals and endocrine disrupting compounds from water
- 1 April 2009
- Published by Elsevier in Water Research
- Vol. 43 (6) , 1513-1522
Evaluation of a photocatalytic reactor membrane pilot system for the removal of pharmaceuticals and endocrine disrupting compounds from water